Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray A Raskind

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Journal of Neurochemistry|November 5, 2004
Chronic cortisol exposure promotes the development of a GABAergic phenotype in the primate hippocampusPamela J McMillan, Charles W Wilkinson, Lynne Greenup, et al.
Brain Research. Molecular Brain Research|July 26, 2005
Alpha1-adrenoreceptor in human hippocampus: binding and receptor subtype mRNA expressionPatricia Szot, Sylvia S White, J Lynne Greenup, et al.
Archives of Neurology|May 13, 2009
Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findingsEric C Petrie, Donna J Cross, Douglas Galasko, et al.
Brain Research|December 15, 2010
Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's diseasePamela J McMillan, Sylvia S White, Allyn Franklin, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 4, 2003
17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary studyLaura D Baker, Kumar Sambamurti, Suzanne Craft, et al.
Neuropharmacology|September 13, 2015
Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrinePatricia Szot, Allyn Franklin, Cristina Miguelez, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|September 13, 2024
Naltrexone augmented with prazosin for alcohol use disorder: results from a randomized controlled proof-of-concept trialTracy L Simpson, Carol Achtmeyer, Lisa Batten, et al.
Biological Psychiatry|September 18, 2007
Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled studyFletcher B Taylor, Patti Martin, Charles Thompson, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 3, 2017
Effect of dietary palmitic and stearic acids on sucrose motivation and hypothalamic and striatal cell signals in the ratDianne P Figlewicz, Jennifer Jay, Constance H West, et al.
Alzheimer Disease and Associated Disorders|March 15, 2005
Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled studyElaine R Peskind, Debby W Tsuang, Lauren T Bonner, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Journal of Neurochemistry|November 5, 2004
Chronic cortisol exposure promotes the development of a GABAergic phenotype in the primate hippocampusPamela J McMillan, Charles W Wilkinson, Lynne Greenup, et al.
Brain Research. Molecular Brain Research|July 26, 2005
Alpha1-adrenoreceptor in human hippocampus: binding and receptor subtype mRNA expressionPatricia Szot, Sylvia S White, J Lynne Greenup, et al.
Archives of Neurology|May 13, 2009
Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findingsEric C Petrie, Donna J Cross, Douglas Galasko, et al.
Brain Research|December 15, 2010
Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's diseasePamela J McMillan, Sylvia S White, Allyn Franklin, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 4, 2003
17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary studyLaura D Baker, Kumar Sambamurti, Suzanne Craft, et al.
Neuropharmacology|September 13, 2015
Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrinePatricia Szot, Allyn Franklin, Cristina Miguelez, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|September 13, 2024
Naltrexone augmented with prazosin for alcohol use disorder: results from a randomized controlled proof-of-concept trialTracy L Simpson, Carol Achtmeyer, Lisa Batten, et al.
Biological Psychiatry|September 18, 2007
Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled studyFletcher B Taylor, Patti Martin, Charles Thompson, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 3, 2017
Effect of dietary palmitic and stearic acids on sucrose motivation and hypothalamic and striatal cell signals in the ratDianne P Figlewicz, Jennifer Jay, Constance H West, et al.
Alzheimer Disease and Associated Disorders|March 15, 2005
Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled studyElaine R Peskind, Debby W Tsuang, Lauren T Bonner, et al.
Pageof 9